ClinicalTrials.Veeva

Menu

FaReWell Depression - Facial Exercise Program to Treat Depression

Z

Zentrum für Angst und Depressionsbehandlung Zürich

Status

Enrolling

Conditions

Depression

Treatments

Behavioral: FaReWell Depression

Study type

Interventional

Funder types

Other

Identifiers

NCT03983291
Version 1.1

Details and patient eligibility

About

This study investigates if a physiotherapeutic exercise program designed to relax facial muscles associated with the expression of negative emotions and to activate and strengthen facial muscles associated with the expression of positive emotions can reduce the symptoms of depression and improve wellbeing and quality of life in the affected patients.

Full description

Activity of the facial musculature expresses emotions, but also generates proprioceptive signals to the emotional brain that maintain and reinforce the expressed emotions. This has been described by Charles Darwin and William James in the facial feedback hypothesis.

Studies have shown that interruption of facial feedback by the injection of botulinum toxin into the corrugator and procerus muscles, which express negative emotions like sadness, anger, and fear, can reduce the symptoms of depression.

In the present study we investigate, if similar effects can be achieved by a relaxing massage of these and other muscles that are associated with the expression of negative emotions and if strengthening exercises of muscles that express positive emotions, the zygomaticus and orbicularis oculi muscles, can contribute to the rehabilitation of positive emotionality in depression. After instruction by a physiotherapist, participants will practice the exercises daily for 15 minutes.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mild to moderate unipolar depression
  • Stable treatment for at least 6 weeks

Exclusion criteria

  • Organic mental disorders
  • Mental disorders due to psychoactive substance use
  • Schizophrenia and other psychotic disorders
  • Previous cosmetic procedures (botulinum toxin, fillers, lifting)
  • Facial palsy
  • Facial skin disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups, including a placebo group

FaReWell Depression
Experimental group
Description:
Physiotherapeutic exercises for the relaxation of facial muscles associated with the expression of negative emotions and for the activation and strengthening of facial muscles associated with the expression of positive emotions 15 minutes daily
Treatment:
Behavioral: FaReWell Depression
Resting exercise
Placebo Comparator group
Description:
Resting 15 minutes daily
Treatment:
Behavioral: FaReWell Depression

Trial contacts and locations

1

Loading...

Central trial contact

Axel Wollmer, MD; Patricia Waldvogel, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems